Back

Genomic analysis of Klebsiella pneumoniae causing community-acquired respiratory deaths among Zambian infants and children using targeted RNA-probe hybridization-capture metagenomics

Lindstedt, K.; Wheelock, A.; Samutela, M.; Kabir, W.; Chasaya, M.; Namuziya, N.; Marsden, E. J.; Kapasa, M.; Mumba, C.; Mulenga, B.; Nkole, L.; Pieciak, R.; Mudenda, V.; Chikoti, C.; Ngoma, B.; Chimoga, C.; Chirwa, S.; Pemba, L.; Nzara, D.; Lungu, J. T.; Forman, L.; Simulundu, E.; MacLeod, W.; Moyo, C.; Somwe, S. W.; Holt, K. E.; Sundsfjord, A.; Gill, C. J.

2026-02-05 microbiology
10.64898/2026.02.02.703236 bioRxiv
Show abstract

Klebsiella pneumoniae (Kp) is a leading cause of neonatal and infant deaths in sub-Saharan Africa and frequently associated with antimicrobial resistance. Previously, we identified Kp as a major cause of fatal community-associated lower respiratory infections among infants and children under five years in Lusaka, Zambia, using postmortem tissue sampling and pathogen specific multiplex qPCR. In this follow-up study, we employed a novel culture-independent RNA-probe hybridization-capture metagenomic sequencing approach, targeting Kp pan-genome core and accessory genes, to perform in-depth genomic analysis of Kp from eleven post-mortem lung biopsy samples from seven of these children. Analysis detected Kp in all cases except one, which identified Klebsiella quasipneumoniae subspecies similipneumoniae. Core-genome multi-locus sequence typing (cgMLST) revealed six clonal groups (CG607, CG1123, CG10072, CG280, CG3648, and CG10344) belonging to five sublineages (SL607, SL17, SL280, SL37, and SL10072), with perfect concordance between paired samples from the same case. Two infants sampled the same month harbored SL607 lineages sharing 621 out of 629 cgMLST alleles, suggesting clonal spread. Kp capsule (K) loci were detected in all but one case and included potential vaccine targets KL25, KL23, and KL122. Antimicrobial resistance genes were widespread among samples, particularly encoding resistance toward aminoglycosides, {beta}-lactams, sulphonamides, tetracyclines, and trimethoprim. Extended spectrum {beta}-lactamases were identified in four cases, three of which were blaCTX-M-15. The acquired Kp sideophore yersiniabactin (lineage ybt14) was identified in both cases associated with SL607, and the acquired siderophore aerobactin (lineage iuc5) was identified in one of these, suggesting possible convergence of antimicrobial resistance and hypervirulence. The detection of Kp with extensive antimicrobial resistance causing fatal community acquired pneumonia signals a deeply concerning epidemiologic shift from a largely nosocomial pathogen. This calls for urgent epidemiological investigations to better understand the burden, transmission dynamics, antimicrobial resistances, and potential vaccine targets for Kp in other community settings across sub-Saharan Africa. Author SummaryKlebsiella pneumoniae is a major cause of infections and death among newborns and young children, particularly in low-income countries, where it is frequently resistant to antibiotics. While well-known as a hospital-associated pathogen, we previously showed K. pneumoniae is also a leading cause of fatal community lung infections among infants and children in Lusaka, Zambia. In this follow-on analysis, we performed deeper genetic analysis of K. pneumoniae detected from the cluster of community pneumonia deaths using lung tissue samples from seven of these children. Since traditional bacterial cultures were unavailable, we instead used a novel approach that enriched and sequenced specific regions of the K. pneumoniae genome directly from the biopsy samples without culturing bacterial isolates. We identified five different K. pneumoniae genetic subtypes, known as sublineages. Two sublineages, which came from children sampled the same month, were highly similar, suggesting clonal spread. Multiple acquired antimicrobial resistance genes were detected across all sublineages. Acquired virulence factors, which may cause more aggressive infections, were also detected in two cases. We also identified capsule types previously suggested as potential vaccine targets. This study underscores the urgent need to better understand and address the emerging burden of antibiotic-resistant K. pneumoniae pneumonia and other invasive infections among infants and children in community settings in sub-Saharan Africa.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Microbial Genomics
204 papers in training set
Top 0.1%
23.1%
2
Journal of Clinical Microbiology
120 papers in training set
Top 0.3%
8.6%
3
The Journal of Infectious Diseases
182 papers in training set
Top 0.3%
7.4%
4
Nature Communications
4913 papers in training set
Top 24%
7.4%
5
Genome Medicine
154 papers in training set
Top 1%
5.0%
50% of probability mass above
6
Scientific Reports
3102 papers in training set
Top 34%
3.7%
7
Clinical Infectious Diseases
231 papers in training set
Top 1%
3.7%
8
PLOS Neglected Tropical Diseases
378 papers in training set
Top 2%
3.7%
9
mBio
750 papers in training set
Top 5%
2.8%
10
Journal of Infection
71 papers in training set
Top 0.8%
2.1%
11
PLOS Pathogens
721 papers in training set
Top 5%
2.1%
12
Nature Microbiology
133 papers in training set
Top 2%
1.7%
13
Emerging Infectious Diseases
103 papers in training set
Top 1%
1.7%
14
mSystems
361 papers in training set
Top 5%
1.7%
15
eLife
5422 papers in training set
Top 45%
1.5%
16
mSphere
281 papers in training set
Top 4%
1.4%
17
The Lancet Microbe
43 papers in training set
Top 0.8%
1.3%
18
Cell Reports Medicine
140 papers in training set
Top 6%
1.0%
19
Cell Host & Microbe
113 papers in training set
Top 4%
1.0%
20
Frontiers in Cellular and Infection Microbiology
98 papers in training set
Top 4%
1.0%
21
International Journal of Infectious Diseases
126 papers in training set
Top 3%
0.9%
22
Emerging Microbes & Infections
74 papers in training set
Top 1%
0.8%
23
Nature Medicine
117 papers in training set
Top 5%
0.8%
24
Open Forum Infectious Diseases
134 papers in training set
Top 3%
0.7%
25
Science
429 papers in training set
Top 21%
0.7%
26
Cell Reports
1338 papers in training set
Top 36%
0.5%
27
The Lancet Infectious Diseases
71 papers in training set
Top 4%
0.5%